TDP-43 and FUS: a nuclear affair

Sleegers, 2010, Molecular pathways of frontotemporal lobar degeneration, Annu. Rev. Neurosci., 33, 71, 10.1146/annurev-neuro-060909-153144 Valdmanis, 2009, Recent advances in the genetics of amyotrophic lateral sclerosis, Curr. Neurol. Neurosci. Rep., 9, 198, 10.1007/s11910-009-0030-9 Boillee, 2006, ALS: a disease of motor neurons and their nonneuronal neighbors, Neuron, 52, 39, 10.1016/j.neuron.2006.09.018 Mackenzie, 2010, TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia, Lancet Neurol., 9, 995, 10.1016/S1474-4422(10)70195-2 Arai, 2006, TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Biochem. Biophys. Res. Commun., 351, 602, 10.1016/j.bbrc.2006.10.093 Neumann, 2009, A new subtype of frontotemporal lobar degeneration with FUS pathology, Brain, 132, 2922, 10.1093/brain/awp214 Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 Kwiatkowski, 2009, Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis, Science, 323, 1205, 10.1126/science.1166066 Vance, 2009, Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6, Science, 323, 1208, 10.1126/science.1165942 Mackenzie, 2010, Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update, Acta Neuropathol., 119, 1, 10.1007/s00401-009-0612-2 Mackenzie, 2007, Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations, Ann. Neurol., 61, 427, 10.1002/ana.21147 Lomen-Hoerth, 2002, The overlap of amyotrophic lateral sclerosis and frontotemporal dementia, Neurology, 59, 1077, 10.1212/WNL.59.7.1077 Murphy, 2007, Continuum of frontal lobe impairment in amyotrophic lateral sclerosis, Arch. Neurol., 64, 530, 10.1001/archneur.64.4.530 Haass, 2004, Take five: BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 Buratti, 2008, Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease, Front. Biosci., 13, 867, 10.2741/2727 Lagier-Tourenne, 2010, TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration, Hum. Mol. Genet., 19, R46, 10.1093/hmg/ddq137 Mackenzie, 2011, Distinct pathological subtypes of FTLD-FUS, Acta Neuropathol., 121, 207, 10.1007/s00401-010-0764-0 Woulfe, 2010, FUS-immunoreactive intranuclear inclusions in neurodegenerative disease, Brain Pathol., 20, 589, 10.1111/j.1750-3639.2009.00337.x Chen-Plotkin, 2010, TAR DNA-binding protein 43 in neurodegenerative disease, Nat. Rev. Neurol., 6, 211, 10.1038/nrneurol.2010.18 Buratti, 2009, The molecular links between TDP-43 dysfunction and neurodegeneration, Adv. Genet., 66, 1, 10.1016/S0065-2660(09)66001-6 Xu, 2010, Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice, J. Neurosci., 30, 10851, 10.1523/JNEUROSCI.1630-10.2010 Igaz, 2011, Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice, J. Clin. Invest., 121, 726, 10.1172/JCI44867 Wils, 2010, TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration, Proc. Natl. Acad. Sci. U.S.A., 107, 3858, 10.1073/pnas.0912417107 Wegorzewska, 2009, TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration, Proc. Natl. Acad. Sci. U.S.A., 106, 18809, 10.1073/pnas.0908767106 Lanson, 2011, A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43, Hum. Mol. Genet., 20, 2510, 10.1093/hmg/ddr150 Kraemer, 2010, Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis, Acta Neuropathol., 119, 409, 10.1007/s00401-010-0659-0 Feiguin, 2009, Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior, FEBS Lett., 583, 1586, 10.1016/j.febslet.2009.04.019 Godena, 2011, TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization, PLoS ONE, 6, e17808, 10.1371/journal.pone.0017808 Wu, 2010, TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis, Genesis, 48, 56 Sephton, 2010, TDP-43 is a developmentally regulated protein essential for early embryonic development, J. Biol. Chem., 285, 6826, 10.1074/jbc.M109.061846 Lee, 2006, Rules for nuclear localization sequence recognition by karyopherin beta 2, Cell, 126, 543, 10.1016/j.cell.2006.05.049 Bosco, 2010, Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules, Hum. Mol. Genet., 19, 4160, 10.1093/hmg/ddq335 Dormann, 2010, ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import, EMBO J., 29, 2841, 10.1038/emboj.2010.143 Gal, 2010, Nuclear localization sequence of FUS and induction of stress granules by ALS mutants, Neurobiol. Aging Kino, 2011, Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations, Nucleic Acids Res., 39, 2781, 10.1093/nar/gkq1162 Ito, 2011, Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS, Ann. Neurol., 69, 152, 10.1002/ana.22246 Chio, 2009, Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation, Neurobiol. Aging, 30, 1272, 10.1016/j.neurobiolaging.2009.05.001 DeJesus-Hernandez, 2010, De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis, Hum. Mutat., 31, E1377, 10.1002/humu.21241 Imasaki, 2007, Structural basis for substrate recognition and dissociation by human transportin 1, Mol. Cell, 28, 57, 10.1016/j.molcel.2007.08.006 Corrado, 2010, Mutations of FUS gene in sporadic amyotrophic lateral sclerosis, J. Med. Genet., 47, 190, 10.1136/jmg.2009.071027 Belzil, 2009, Mutations in FUS cause FALS and SALS in French and French Canadian populations, Neurology, 73, 1176, 10.1212/WNL.0b013e3181bbfeef Rademakers, 2010, Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis, Muscle Nerve, 42, 170, 10.1002/mus.21665 Ticozzi, 2009, Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort, Neurology, 73, 1180, 10.1212/WNL.0b013e3181bbff05 Yan, 2010, Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia, Neurology, 75, 807, 10.1212/WNL.0b013e3181f07e0c Buratti, 2005, TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing, J. Biol. Chem., 280, 37572, 10.1074/jbc.M505557200 Winton, 2008, Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation, J. Biol. Chem., 283, 13302, 10.1074/jbc.M800342200 Ayala, 2008, Structural determinants of the cellular localization and shuttling of TDP-43, J. Cell Sci., 121, 3778, 10.1242/jcs.038950 Winton, 2008, A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro, FEBS Lett., 582, 2252, 10.1016/j.febslet.2008.05.024 Guerreiro, 2008, TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis, PLoS ONE, 3, e2450, 10.1371/journal.pone.0002450 Kabashi, 2008, TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis, Nat. Genet., 40, 572, 10.1038/ng.132 Corrado, 2009, High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis, Hum. Mutat., 30, 688, 10.1002/humu.20950 Sreedharan, 2008, TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis, Science, 319, 1668, 10.1126/science.1154584 Benajiba, 2009, TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration, Ann. Neurol., 65, 470, 10.1002/ana.21612 Barmada, 2010, Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis, J. Neurosci., 30, 639, 10.1523/JNEUROSCI.4988-09.2010 Johnson, 2009, TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity, J. Biol. Chem., 284, 20329, 10.1074/jbc.M109.010264 Nonaka, 2009, Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43, Hum. Mol. Genet., 18, 3353, 10.1093/hmg/ddp275 Rademakers, 2007, The genetics of frontotemporal lobar degeneration, Curr. Neurol. Neurosci. Rep., 7, 434, 10.1007/s11910-007-0067-6 Cansizoglu, 2007, Structure-based design of a pathway-specific nuclear import inhibitor, Nat. Struct. Mol. Biol., 14, 452, 10.1038/nsmb1229 Kosugi, 2008, Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling, Chem. Biol., 15, 940, 10.1016/j.chembiol.2008.07.019 Nishimura, 2010, Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration, Brain, 133, 1763, 10.1093/brain/awq111 Kutay, 1997, Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor, Cell, 90, 1061, 10.1016/S0092-8674(00)80372-4 Lu, 2004, Gene regulation and DNA damage in the ageing human brain, Nature, 429, 883, 10.1038/nature02661 Muhlhausser, 2001, Multiple pathways contribute to nuclear import of core histones, EMBO Rep., 2, 690, 10.1093/embo-reports/kve168 Paschal, 1995, Identification of NTF2, a cytosolic factor for nuclear import that interacts with nuclear pore complex protein p62, J. Cell Biol., 129, 925, 10.1083/jcb.129.4.925 Berchtold, 2008, Gene expression changes in the course of normal brain aging are sexually dimorphic, Proc. Natl. Acad. Sci. U.S.A., 105, 15605, 10.1073/pnas.0806883105 Wente, 2010, The nuclear pore complex and nuclear transport, Cold Spring Harb. Perspect. Biol., 2, a000562, 10.1101/cshperspect.a000562 D’Angelo, 2009, Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells, Cell, 136, 284, 10.1016/j.cell.2008.11.037 Zakaryan, 2006, Identification and characterization of the nuclear localization/retention signal in the EWS proto-oncoprotein, J. Mol. Biol., 363, 27, 10.1016/j.jmb.2006.08.018 Guttinger, 2004, Transportin2 functions as importin and mediates nuclear import of HuR, Proc. Natl. Acad. Sci. U.S.A., 101, 2918, 10.1073/pnas.0400342101 Anderson, 2008, Stress granules: the Tao of RNA triage, Trends Biochem. Sci., 33, 141, 10.1016/j.tibs.2007.12.003 Liu-Yesucevitz, 2010, Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue, PLoS ONE, 5, e13250, 10.1371/journal.pone.0013250 Fujita, 2008, Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease, Acta Neuropathol., 116, 439, 10.1007/s00401-008-0415-x Volkening, 2009, Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS), Brain Res., 1305, 168, 10.1016/j.brainres.2009.09.105 Kedersha, 2007, Mammalian stress granules and processing bodies, Methods Enzymol., 431, 61, 10.1016/S0076-6879(07)31005-7 Bedford, 2009, Protein arginine methylation in mammals: who, what, and why, Mol. Cell, 33, 1, 10.1016/j.molcel.2008.12.013 Terry, 2007, Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport, Science, 318, 1412, 10.1126/science.1142204 Neumann, 2009, Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies, Acta Neuropathol., 117, 137, 10.1007/s00401-008-0477-9 Hasegawa, 2008, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Ann. Neurol., 64, 60, 10.1002/ana.21425 Rappsilber, 2003, Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode, Anal. Chem., 75, 3107, 10.1021/ac026283q Igaz, 2008, Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Am. J. Pathol., 173, 182, 10.2353/ajpath.2008.080003 Dormann, 2009, Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin, J. Neurochem., 110, 1082, 10.1111/j.1471-4159.2009.06211.x Pesiridis, 2011, A ‘two hit’ hypothesis for inclusion formation by carboxy terminal fragments of TDP-43 linked to RNA depletion and impaired microtubule dependent transport, J. Biol. Chem., 286, 18845, 10.1074/jbc.M111.231118 Shaw, 2008, Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?, Neuromol. Med., 10, 1, 10.1007/s12017-007-8016-8 Geser, 2008, Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam, Acta Neuropathol., 115, 133, 10.1007/s00401-007-0257-y Hasegawa, 2007, TDP-43 is deposited in the Guam parkinsonism–dementia complex brains, Brain, 130, 1386, 10.1093/brain/awm065 Maekawa, 2009, TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations, Neuropathology, 29, 672, 10.1111/j.1440-1789.2009.01029.x Van Damme, 2008, Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival, J. Cell Biol., 181, 37, 10.1083/jcb.200712039 Wojcik, 2006, Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells, Mol. Biol. Cell, 17, 4606, 10.1091/mbc.E06-05-0432 Ayala, 2011, TDP-43 regulates its mRNA levels through a negative feedback loop, EMBO J., 30, 277, 10.1038/emboj.2010.310 Polymenidou, 2011, Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43, Nat. Neurosci., 14, 459, 10.1038/nn.2779 Zinszner, 1997, TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling, J. Cell Sci., 110, 1741, 10.1242/jcs.110.15.1741 Cushman, 2010, Prion-like disorders: blurring the divide between transmissibility and infectivity, J. Cell Sci., 123, 1191, 10.1242/jcs.051672 Udan, 2011, Implications of the prion-related Q/N domains in TDP-43 and FUS, Prion, 5, 1, 10.4161/pri.5.1.14265 Sun, 2011, Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS, PLoS Biol., 9, e1000614, 10.1371/journal.pbio.1000614 Johnson, 2008, A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity, Proc. Natl. Acad. Sci. U.S.A., 105, 6439, 10.1073/pnas.0802082105 Kryndushkin, 2011, FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis, Prot. Cell, 2, 223, 10.1007/s13238-011-1525-0 Fushimi, 2011, Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy, Prot. Cell, 2, 141, 10.1007/s13238-011-1014-5 Ju, 2011, A yeast model of FUS/TLS-dependent cytotoxicity, PLoS Biol., 9, e1001052, 10.1371/journal.pbio.1001052 Furukawa, 2011, A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble TAR DNA binding protein-43 inclusions, J. Biol. Chem., 286, 18664, 10.1074/jbc.M111.231209 Aguzzi, 2009, The transcellular spread of cytosolic amyloids, prions, and prionoids, Neuron, 64, 783, 10.1016/j.neuron.2009.12.016 Brundin, 2010, Prion-like transmission of protein aggregates in neurodegenerative diseases, Nat. Rev. Mol. Cell Biol., 11, 301, 10.1038/nrm2873 Sephton, 2011, Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes, J. Biol. Chem., 286, 1204, 10.1074/jbc.M110.190884 Tollervey, 2011, Characterizing the RNA targets and position-dependent splicing regulation by TDP-43, Nat. Neurosci., 14, 452, 10.1038/nn.2778 Elden, 2010, Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS, Nature, 466, 1069, 10.1038/nature09320 Wilson, 2011, TDP-43 in aging and Alzheimer's disease - a review, Int. J. Clin. Exp. Pathol., 4, 147 Uryu, 2008, Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies, J. Neuropathol. Exp. Neurol., 67, 555, 10.1097/NEN.0b013e31817713b5 Arai, 2009, Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies, Acta Neuropathol., 117, 125, 10.1007/s00401-008-0480-1 Amador-Ortiz, 2007, TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease, Ann. Neurol., 61, 435, 10.1002/ana.21154 Lippa, 2009, Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome, Arch. Neurol., 66, 1483, 10.1001/archneurol.2009.277 Josephs, 2008, Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype, Neurology, 70, 1850, 10.1212/01.wnl.0000304041.09418.b1 Chu, 2007, Location, location, location: altered transcription factor trafficking in neurodegeneration, J. Neuropathol. Exp. Neurol., 66, 873, 10.1097/nen.0b013e318156a3d7 Crozat, 1993, Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma, Nature, 363, 640, 10.1038/363640a0 Rabbitts, 1993, Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma, Nat. Genet., 4, 175, 10.1038/ng0693-175 Iko, 2004, Domain architectures and characterization of an RNA-binding protein, TLS, J. Biol. Chem., 279, 44834, 10.1074/jbc.M408552200 Lagier-Tourenne, 2009, Rethinking ALS: the FUS about TDP-43, Cell, 136, 1001, 10.1016/j.cell.2009.03.006 Ou, 1995, Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, J. Virol., 69, 3584, 10.1128/JVI.69.6.3584-3596.1995 Buratti, 2001, Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9, J. Biol. Chem., 276, 36337, 10.1074/jbc.M104236200 Baker, 2006, Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17, Nature, 442, 916, 10.1038/nature05016 Cruts, 2006, Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21, Curr. Alz. Res., 3, 485, 10.2174/156720506779025251 Van Langenhove, 2010, Genetic contribution of FUS to frontotemporal lobar degeneration, Neurology, 74, 366, 10.1212/WNL.0b013e3181ccc732 Seilhean, 2009, Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation, Acta Neuropathol., 118, 561, 10.1007/s00401-009-0545-9 Johnson, 2010, Exome sequencing reveals VCP mutations as a cause of familial ALS, Neuron, 68, 857, 10.1016/j.neuron.2010.11.036 Prasad, 1994, TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain, Oncogene, 9, 3717 Lerga, 2001, Identification of an RNA binding specificity for the potential splicing factor TLS, J. Biol. Chem., 276, 6807, 10.1074/jbc.M008304200 Zhang, 2009, Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity, Proc. Natl. Acad. Sci. U.S.A., 106, 7607, 10.1073/pnas.0900688106 Lange, 2007, Classical nuclear localization signals: definition, function, and interaction with importin alpha, J. Biol. Chem., 282, 5101, 10.1074/jbc.R600026200 Steggerda, 2002, Regulation of nuclear import and export by the GTPase Ran, Int. Rev. Cytol., 217, 41, 10.1016/S0074-7696(02)17012-4 Xu, 2010, Recognition of nuclear targeting signals by Karyopherin-beta proteins, Curr. Opin. Struct. Biol., 20, 782, 10.1016/j.sbi.2010.09.008